2  Speaker Profiles

2.1 Prof. Dianna Magliano, PhD, OAM

Professor Dianna Magliano has a BAppSci (Hons), PhD, and a Master of Public Health. Professor Magliano has worked for over 20 years in epidemiology, the majority in diabetes, cardiovascular disease and obesity research. Her more recent work involves exploring the trends in diabetes incidence, diabetes complications and mortality across the globe and she heads a consortium of 24 collaborators to do this work. She is the current co-chair of the IDF Diabetes Atlas and is an Associate Editor for Diabetologia and a visiting professor at Steno Diabetes Center Copenhagen on the project - Harnessing Multiple Large Datasets to Answer Questions on Diabetes Epidemiology – International Centre for Population-Based Diabetes Research (IPoD) funded by the DDEA (Danish Diabetes and Endocrine Academy).

2.2 Mr. Bendix Carstensen, MSc.

Bendix Carstensen has been a senior statistician at Steno Diabetes Center Copenhagen since 1999. He holds a degree in mathematical statistics from the University of Copenhagen. He has mostly worked with demographic aspects of diabetes, including maintaining a Danish diabetes register. He is the maintainer of the Epi package for R and the author of “Epidemiology with R” (OUP, 2021). He has extensive experience with international collaborations on monitoring and modelling of diabetes epidemiology and demography.

2.3 Dr. Edward W Gregg, PhD

Edward Gregg holds dual appointments at Imperial College London, UK (School of Public Health), and the Royal College of Surgeons in Ireland. He previously led a multi-disciplinary public health science unit in the Division of Diabetes Translation at the U.S. Centers for Disease Control and Prevention where he championed the role of epidemiology for public health decision-making through diverse disciplines, including population surveillance, effectiveness trials, natural experiments, and health impact modelling. He has particular interests in the factors driving recent trends in the diabetes epidemic and the impact of lifestyle interventions and related health policies on diabetes, cardiovascular disease, and ageing-related outcomes.

2.4 Prof. Henrik Støvring, PhD

Henrik Støvring has investigated the diabetes epidemic in Denmark during the 1990s using pharmacoepidemiologic data and showed how projections of future prevalence must incorporate developments in both incidence and mortality. He has developed new statistical methods for analyses with pharmacoepidemiologic data and has been leading research on the effects of screening for cancer and developments in diabetes mortality.

2.5 Dr. Hanne Løvdal Gulseth, MD,PhD

Hanne Løvdal Gulseth is Department Director at the Norwegian Institute of Public Health and Oslo University Hospital. Her research focuses on nutrition, diabetes and the metabolic syndrome, with special emphasis on vitamin D.

2.6 Prof. Sarah Wild, PhD

Sarah Wild is professor of Epidemiology at the Centre for Population Health Sciences, University of Edinburgh. Her main interests are the epidemiology and prevention of diabetes and other non-communicable diseases, particularly among women and different socio-economic and ethnic groups, and the use of routine data for research. Sarah Wild did her medical training in London and Cambridge. Her postgraduate experience included general medicine and diabetes, general practice and public health medicine, a cardiovascular epidemiology fellowship at Stanford University and a PhD at the London School of Hygiene and Tropical Medicine. She is one of the leading forced behind the SCI Diabetes register that covers all diabetes patients in Scotland.

2.7 Prof. Daniel R. Witte, PhD

Daniel Witte is professor of Diabetes Epidemiology at Aarhus University and Steno Diabetes Center Aarhus. He focuses mainly on the pathophysiological mechanisms that drive the transition from normal glucose control to pre-diabetes and diabetes at the population level. Additional work includes early stages of diabetic complications, their management, and long-term consequences. He has a special focus on longitudinal trajectory analyses and clustering of diabetic complications and risk factors. He is the Principal Investigator of the DP-Next project.